Guardant Health
GH
#3106
Rank
$3.91 B
Marketcap
$31.67
Share price
1.73%
Change (1 day)
25.57%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Cash on Hand

Cash on Hand as of September 2024 : $0.99 Billion USD

According to Guardant Health 's latest financial reports the company has $0.99 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Guardant Health - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$1.16 B15.57%
2022-12-31$1.01 B8.41%
2021-12-31$0.93 B-48.03%
2020-12-31$1.79 B243.32%
2019-12-31$0.52 B24.79%
2018-12-31$0.41 B89.3%
2017-12-31$0.22 B132.34%
2016-12-31$95.25 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.92 B-7.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.12 B-87.94%๐Ÿ‡บ๐Ÿ‡ธ USA